Percentages of TCD8+ lymphocytes expressing CD18+ were similar in SS and SR patients (7.4 ± 0.8% in SS vs. 8.0 ± 2.0% in SR, p = 0.87, Figure 3B). This evidence concerns the gene ITGB2 and synovial sarcoma.